GlassScriptPhysician profile
Abhijit Chatterjee
NPI 1487692836
$783.01
in general payments reported to CMS, 2019-2025
11 companies · $17.10 in 2025
The $17.10 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $42.19 · 2022: $34.00 · 2023: $49.85 · 2024: $464 · 2025: $17.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $214.03 | 2024 | Novosorb Btm |
| Suvon Surgical LLC | $139.56 | 2024 | |
| Astellas Pharma US INC | $131.80 | 2019-2020 | |
| Stryker Corporation | $127.06 | 2023-2024 | T2 Alpha, Gamma |
| Janssen Pharmaceuticals, INC | $71.10 | 2019-2022 | |
| Smith+Nephew, INC. | $19.09 | 2022 | |
| Lilly USA, LLC | $18.66 | 2024 | Amyvid |
| Almatica Pharma LLC | $17.10 | 2025 | Teriparatide |
| Pfizer INC. | $14.92 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $14.88 | 2020 | |
| Merck Sharp & Dohme LLC | $14.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhijit Chatterjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.